Comprehensive Epilepsy is categorized under Internal Medicine Doctors in Charlottesville, VA and active since 2010.
Comprehensive Epilepsy was established in 2010, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Kahterine Ward at the company’s single location by writing to 1 Hospital Drive # 2027, Charlottesville, Virginia VA 22908 or by phoning (434) 924-5401. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Comprehensive Epilepsy |
| Contact Person: | Kahterine Ward |
| Address: | 1 Hospital Drive # 2027, Charlottesville, Virginia 22908 |
| Phone Number: | (434) 924-5401 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Comprehensive Epilepsy was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Kahterine Ward for inquiries that concern Comprehensive Epilepsy by calling the company number (434) 924-5401, as your correspondence is most welcome. Additionally, the physical location of the single location of Comprehensive Epilepsy can be found at the coordinates 38.03545,-78.51491 as well as the street address 1 Hospital Drive # 2027 in Charlottesville, Virginia 22908.
For its online presence, you may visit Comprehensive Epilepsy’s website at and engage with its social media outlets through on Twitter and on Facebook.